The NLRP3 Inflammasome Is a Major Cause of Acute Renal Failure Induced by Polypeptide Antibiotics
The Journal of Immunology · 2024
DOI: 10.4049/jimmunol.2300193 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2024. Verfasst von Tomohiro Kagi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan. Hauptthemen laut MEDLINE: Acute Kidney Injury, NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes, Macrophages. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development (AMED), MEXT | Japan Society for the Promotion of Science (JSPS).
Abstract (Originalsprache)
Drug-induced acute renal failure (ARF) is a public health concern that hinders optimal drug therapy. However, pathological mechanisms of drug-induced ARF remain to be elucidated. Here, we show that a pathological process of drug-induced ARF is mediated by proinflammatory cross-talk between kidney tubular cells and macrophages. Both polymyxin B and colistin, polypeptide antibiotics, frequently cause ARF, stimulated the ERK and NF-κB pathways in kidney tubular cells, and thereby upregulated M-CSF and MCP-1, leading to infiltration of macrophages into the kidneys. Thereafter, the kidney-infiltrated macrophages were exposed to polypeptide antibiotics, which initiated activation of the NLR family pyrin domain containing 3 (NLRP3) inflammasome. Interestingly, blockade of the NLRP3 activation clearly ameliorated the pathology of ARF induced by polypeptide antibiotics, suggesting that a combination of the distinct cellular responses to polypeptide antibiotics in kidney tubular cells and macrophages plays a key role in the pathogenesis of colistin-induced ARF. Thus, our results provide a concrete example of how drugs initiate ARF, which may give insight into the underlying pathological process of drug-induced ARF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Health Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
- Laboratory of Environmental and Health Sciences, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
- Department of Environmental Toxicology, Meiji Pharmaceutical University, Tokyo, Japan.
ORCID-Profile: Takuya Noguchi, Wakana Suzuki, Yusuke Hirata, Sawako Shindo, Gi-Wook Hwang, Atsushi Matsuzawa
Förderung
- Japan Agency for Medical Research and Development (AMED)
- MEXT | Japan Society for the Promotion of Science (JSPS)
Zitieren
APA
Kagi, T., Inoue, A., Noguchi, T., Suzuki, W., Takano, S., Otani, K., Naganuma, R., Sekiguchi, Y., Hirata, Y., Shindo, S., Hwang, G. W., & Matsuzawa, A. (2024). The NLRP3 Inflammasome Is a Major Cause of Acute Renal Failure Induced by Polypeptide Antibiotics. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2300193
Vancouver
Kagi T, Inoue A, Noguchi T, Suzuki W, Takano S, Otani K, et al. The NLRP3 Inflammasome Is a Major Cause of Acute Renal Failure Induced by Polypeptide Antibiotics. The Journal of Immunology. 2024. doi:10.4049/jimmunol.2300193
BibTeX
@article{Kagi2024,
author = {Kagi, Tomohiro and Inoue, Aya and Noguchi, Takuya and Suzuki, Wakana and Takano, Saya and Otani, Kohei and Naganuma, Rio and Sekiguchi, Yuto and Hirata, Yusuke and Shindo, Sawako and Hwang, Gi-Wook and Matsuzawa, Atsushi},
title = {The NLRP3 Inflammasome Is a Major Cause of Acute Renal Failure Induced by Polypeptide Antibiotics},
journal = {The Journal of Immunology},
year = {2024},
doi = {10.4049/jimmunol.2300193}
}
EUVIMED